Renal Division, Department of Internal Medicine, University Hospital, Gent, Belgium.
Nephron Clin Pract. 2010;114(3):c165-72. doi: 10.1159/000262298. Epub 2009 Nov 28.
Chronic kidney disease is characterized by the progressive retention of a number of compounds, several of which have the potential to cause cardiovascular damage. Many of these are difficult to remove by standard dialysis strategies. Removal of the larger middle molecules (mostly larger peptidic compounds) can be obtained by increasing dialyzer pore size and/or by applying convective strategies. For protein-bound solutes, convection (essentially hemodiafiltration) positively affects removal. The HEMO study demonstrated outcome superiority for the large-pore high-flux hemodialysis membranes in a number of subgroup analyses. Likewise, the Membrane Permeability Outcome study showed outcome superiority for high flux in patients with serum albumin <4 g/dl, the group for which the study had originally been designed. Apart from a small controlled trial, data suggesting superiority for convective strategies are all observational.
慢性肾脏病的特征是多种化合物的进行性蓄积,其中有几种化合物有可能导致心血管损伤。其中许多化合物通过标准透析策略难以清除。通过增加透析器的孔径和/或应用对流策略,可以去除较大的中分子物质(主要是较大的肽类化合物)。对于与蛋白结合的溶质,对流(基本上是血液透析滤过)可正向影响清除率。HEMO 研究在多项亚组分析中证实了大孔径高通量血液透析膜的结局优势。同样,膜通透性结局研究也显示了在血清白蛋白<4 g/dl 的患者中高通量的结局优势,这是该研究最初设计的人群。除了一项小型对照试验外,提示对流策略具有优势的数据均为观察性研究。